Long-term Muscle Synthetic Effects of Intradialytic Parenteral Nutrition in Chronic Hemodialysis … (NCT07254897) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Long-term Muscle Synthetic Effects of Intradialytic Parenteral Nutrition in Chronic Hemodialysis Patients
Netherlands16 participantsStarted 2026-01-01
Plain-language summary
This study examines the effects of intradialytic parenteral nutrition (IDPN) on muscle growth and blood pressure in patients undergoing chronic hemodialysis.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age above 18 years
* Receiving HD treatment over 3 months
* Receiving HD treatment 3 times per week for at least 4 hours per session
* 24-hour urine production \< 100 mL
* Adequate dialysis dose (eKt/V over 1.2)
* AV fistula with blood flow (measured invasively or by Doppler ultrasound) over 750 mL/min
Exclusion Criteria:
* Occurrence of intradialytic hypotension in the last month, defined by systolic blood pressure \< 90 mm Hg combined with a nursing intervention
* Hospitalization \< 3 months before inclusion
* Active infection or inflammation at randomization
* Use of oral or intravenous corticosteroids
* Incapacitation
* Patients who are not expected to be able to complete the study protocol (e.g., due to a planned kidney transplantation within the planned study time frame)
* Pregnancy
* Use of oral anticoagulants or antiplatelet agents that cannot be safely stopped during the study
* Diabetes mellitus
* AV fistula with recirculation
What they're measuring
1
Myofibrillar fractional synthetic rate
Timeframe: At baseline and during the first dialysis sessions in the following two weeks.